The Lobbying Register, read carefully Epicycle

Returns

Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.

Clear all

Showing returns filed by Pfizer .

Filed returns
111
match these filters
Matching filed returns per period 0 2 5 7 10 Sep–Dec 2015: 2 filed returns May–Aug 2016: 3 filed returns Sep–Dec 2016: 4 filed returns Jan–Apr 2017: 4 filed returns May–Aug 2017: 3 filed returns Sep–Dec 2017: 7 filed returns Jan–Apr 2018: 2 filed returns Sep–Dec 2018: 2 filed returns Jan–Apr 2019: 1 filed returns May–Aug 2019: 2 filed returns Jan–Apr 2020: 1 filed returns May–Aug 2020: 3 filed returns Sep–Dec 2020: 3 filed returns Jan–Apr 2021: 5 filed returns May–Aug 2021: 5 filed returns Sep–Dec 2021: 5 filed returns Jan–Apr 2022: 3 filed returns May–Aug 2022: 6 filed returns Sep–Dec 2022: 6 filed returns Jan–Apr 2023: 6 filed returns May–Aug 2023: 3 filed returns Sep–Dec 2023: 4 filed returns Jan–Apr 2024: 3 filed returns May–Aug 2024: 3 filed returns Sep–Dec 2024: 5 filed returns Jan–Apr 2025: 5 filed returns May–Aug 2025: 4 filed returns Sep–Dec 2025: 3 filed returns Jan–Apr 2026: 5 filed returns May–Aug 2026: 3 filed returns 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Filed returns per four-month period Click a column to list its returns.
PeriodRegistrantPolicy areaSubject, as filedOfficials namedLink
May–Aug 2026 Pfizer Health Discussion on the EU Biotech Act, access to medicines, innovation, and Ireland's life sciences policy environment, including opportunities to strengthen research, development, manufacturing, and the competitiveness of… (Public policy or programme) 3 On lobbying.ie
May–Aug 2026 Pfizer EU Affairs Ireland’s priorities for the 2026 Presidency of the Council of the European Union, including issues related to life sciences competitiveness (Public policy or programme) 5 On lobbying.ie
May–Aug 2026 Pfizer Health Expansion of the National Immunisation Programme to include RSV vaccination for older adults (Public policy or programme) 16 On lobbying.ie
Jan–Apr 2026 Pfizer Health Ireland’s National Life Sciences Strategy (Public policy or programme) 1 On lobbying.ie
Jan–Apr 2026 Pfizer Health Ireland's medicine reimbursement system and access to new medicine (Matters involving public funds) 2 On lobbying.ie
Jan–Apr 2026 Pfizer EU Affairs Ireland’s priorities for the 2026 Presidency of the Council of the European Union, including issues related to life sciences competitiveness, pharmaceutical manufacturing, and EU-level health emergency preparedness (Public policy or programme) 3 On lobbying.ie
Jan–Apr 2026 Pfizer Health Expansion of the National Immunisation Programme to include RSV vaccination for older adults (Public policy or programme) 16 On lobbying.ie
Jan–Apr 2026 Pfizer Trade Geopolitical polices in relation to tariffs and Most Favoured Nation (MFN) pricing (Public policy or programme) 4 On lobbying.ie
Sep–Dec 2025 Pfizer EU Affairs Ireland priorities for the Presidency of the Council of the European Union (Public policy or programme) 2 On lobbying.ie
Sep–Dec 2025 Pfizer Health Ireland's medicine reimbursement system and funding for access to new medicines and vaccines (Matters involving public funds) 4 On lobbying.ie
Sep–Dec 2025 Pfizer Health Expansion of the National Immunisation Programme to include RSV vaccination for older adults (Public policy or programme) 19 On lobbying.ie
May–Aug 2025 Pfizer Taxation Reform of R&D tax credit (Matters involving public funds) 2 On lobbying.ie
May–Aug 2025 Pfizer Health Ireland's medicine reimbursement system and funding for access to new medicines and vaccines (Matters involving public funds) 9 On lobbying.ie
May–Aug 2025 Pfizer Trade Raise concern about the impact of potential tariffs and related geo-political issues related to the pharmaceutical industry and pricing of medicines globally (Public policy or programme) 11 On lobbying.ie
May–Aug 2025 Pfizer Health Expansion of the National Immunisation Programme to include RSV protection for infants and older adults (Public policy or programme) 9 On lobbying.ie
Jan–Apr 2025 Pfizer Health Treatment of Amyloidosis and ATTR-CM M (Public policy or programme) 1 On lobbying.ie
Jan–Apr 2025 Pfizer Health Expansion of the National Immunisation Programme to include RSV protection for infants and older adults (Public policy or programme) 6 On lobbying.ie
Jan–Apr 2025 Pfizer Trade Raise concern about the impact of potential tariffs on pharmaceutical manufacturing and supply of medicines to patients globally (Public policy or programme) 11 On lobbying.ie
Jan–Apr 2025 Pfizer EU Affairs EU Pharmaceutical Legislation proposals (Legislation) 7 On lobbying.ie
Jan–Apr 2025 Pfizer Health Ireland's medicine reimbursement system and funding for access to new medicines and vaccines (Matters involving public funds) 7 On lobbying.ie
Sep–Dec 2024 Pfizer EU Affairs PFAS restrictions (Legislation) 1 On lobbying.ie
Sep–Dec 2024 Pfizer Health Access to an antiviral medication for the treatment of COVID-19 (Matters involving public funds) 5 On lobbying.ie
Sep–Dec 2024 Pfizer Economic Development and Industry Life Science Strategy and Industrial Policy (Public policy or programme) 8 On lobbying.ie
Sep–Dec 2024 Pfizer EU Affairs EU Pharmaceutical Legislation proposals (Legislation) 6 On lobbying.ie
Sep–Dec 2024 Pfizer Health Ireland's medicine reimbursement system and funding for access to new medicines and vaccines (Matters involving public funds) 15 On lobbying.ie
May–Aug 2024 Pfizer Health Digital Policy and the Life Science Industry (Public policy or programme) 1 On lobbying.ie
May–Aug 2024 Pfizer Health Ireland's medicine reimbursement system and access to new medicines and vaccines (Matters involving public funds) 1 On lobbying.ie
May–Aug 2024 Pfizer EU Affairs EU Pharmaceutical Legislation proposals (Legislation) 14 On lobbying.ie
Jan–Apr 2024 Pfizer Taxation Proposed changes to global taxation at the OECD and by the U.S. administration (Public policy or programme) 2 On lobbying.ie
Jan–Apr 2024 Pfizer EU Affairs EU Pharmaceutical Legislation proposals (Legislation) 9 On lobbying.ie
Jan–Apr 2024 Pfizer Health Ireland's medicine reimbursement system and access to new medicines and vaccines (Matters involving public funds) 14 On lobbying.ie
Sep–Dec 2023 Pfizer Health Exchange about the burden of sickle-cell disease in Europe and the Pfizer-supported call to action Shaping the Change for Sickle Cell Disease Patients in Europe and Beyond. (Public policy or programme) 1 On lobbying.ie
Sep–Dec 2023 Pfizer EU Affairs Urban Wastewater Treatment Directive (UWWTD) (Legislation) 1 On lobbying.ie
Sep–Dec 2023 Pfizer Health Migraine Summit (Public policy or programme) 1 On lobbying.ie
Sep–Dec 2023 Pfizer Health Ireland's medicine reimbursement system and Budget funding for new medicines (Matters involving public funds) 9 On lobbying.ie
May–Aug 2023 Pfizer Taxation Proposed changes to global taxation at the OECD and by the U.S. administration (Public policy or programme) 2 On lobbying.ie
May–Aug 2023 Pfizer EU Affairs EU Pharmaceutical Legislation proposals (Legislation) 5 On lobbying.ie
May–Aug 2023 Pfizer Health Ireland's reimbursement system and funding for new medicines (Public policy or programme) 6 On lobbying.ie
Jan–Apr 2023 Pfizer Taxation Proposed changes to global taxation at the OECD and by the U.S. administration (Public policy or programme) 2 On lobbying.ie
Jan–Apr 2023 Pfizer EU Affairs Potential EU proposals to restrict use of titanium dioxide and PFAS in medicines (Legislation) 1 On lobbying.ie
Jan–Apr 2023 Pfizer Economic Development and Industry Pfizer recent 1.2 billion euro investment in Ireland operations creating 400-500 jobs (Public policy or programme) 13 On lobbying.ie
Jan–Apr 2023 Pfizer Health Ireland's pricing and reimbursement system and funding for new medicines (Public policy or programme) 14 On lobbying.ie
Jan–Apr 2023 Pfizer EU Affairs EU Pharmaceutical Legislation (Legislation) 3 On lobbying.ie
Jan–Apr 2023 Pfizer EU Affairs EC HERA contract in relation to Pfizer COVID-19 vaccine (Matters involving public funds) 5 On lobbying.ie
Sep–Dec 2022 Pfizer EU Affairs European System of Accounts (EU Accounting Rules) (Legislation) 1 On lobbying.ie
Sep–Dec 2022 Pfizer Health Pfizer anti-viral COVID-19 treatment and COVID-19 cases (Public policy or programme) 1 On lobbying.ie
Sep–Dec 2022 Pfizer EU Affairs EC HERA contract in relation to Pfizer COVID-19 vaccine (Matters involving public funds) 5 On lobbying.ie
Sep–Dec 2022 Pfizer Energy and Natural Resources Potential energy shortages (Public policy or programme) 7 On lobbying.ie
Sep–Dec 2022 Pfizer Budgetary matters Budget 2023 (Public policy or programme) 8 On lobbying.ie
Sep–Dec 2022 Pfizer Economic Development and Industry COVID-19 Trips waiver - vaccines and therapeutics (Public policy or programme) 7 On lobbying.ie

Policy areas in these returns

Public policy areaFiled returnsShareRelative to the largest
Health 56 50.5%
EU Affairs 21 18.9%
Economic Development and Industry 17 15.3%
Taxation 9 8.1%
Trade 4 3.6%
Budgetary matters 2 1.8%
Energy and Natural Resources 1 0.9%
Transport 1 0.9%